NewsWhore
04-22-2008, 11:20 AM
LONDON (Thomson Financial) - Buyers were nibbling at shares in bio-pharmaceutical company Lipoxen, a penny firmer at 19-1/2, following positive initial results from the first Phase I trial of ErepoXen...
More... (http://story.brazilsun.com/index.php/ct/9/cid/24437442923341f1/id/14338004/)
More... (http://story.brazilsun.com/index.php/ct/9/cid/24437442923341f1/id/14338004/)